<DOC>
	<DOCNO>NCT00112411</DOCNO>
	<brief_summary>This study design evaluate single-dose effectiveness two bronchodilator inhaler give two dose level pediatric asthma patient .</brief_summary>
	<brief_title>Comparison Two Bronchodilator Inhalers Pediatric Asthmatics</brief_title>
	<detailed_description />
	<mesh_term>Bronchodilator Agents</mesh_term>
	<criteria>Persistent asthma minimum six month duration stable least four week Predicted FEV1 6090 % Demonstration 12 % airway reversibility Continuous requirement betablockers , monoamine oxidase ( MAO ) inhibitor , tricyclic antidepressant , anticholinergic and/or steroid inhale ; Presence clinicallysignificant nonasthmatic acute chronic disease</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>December 2005</verification_date>
</DOC>